ClinicalTrials.gov
public full text
Public Domain
IASO-782 in Systemic Lupus Erythematosus
his study is a randomized, double-blinded, and placebo-controlled phase Ia clinical study in subjects with SLE. The study is designed to assess the safety and tolerability of IASO-782 for the treatment of SLE.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- IASO207 Injection for Active Refractory Systemic Lupus Erythematosus (SLE)#1363340
- UC-MSC Cell Therapy Study for Systemic Lupus Erythematosus (SLE) Patients#838628
- Anemia in Systemic Lupus Erythematosus Specially Refractory Type#1137998
- " TREX1 Gene Mutations and Their Role in Systemic Lupus Erythematosus#853515
- Double humanised lupus mouse model with human immune system and faecal microbiota from patients with SLE.#171985
Record · ID 1195077
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive